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Abstract 
The Pima Indians of Arizona have the highest reported prevalence and incidence of non-insulin-dependent 
diabetes mellitus (NIDDM) of any population in the world. A cross-sectional and longitudinal study was 
begun in 1982 to determine the metabolic characteristic(s) that is (are) predictive of the development of 
NIDDM and to document the sequence of metabolic events that occur with the transition from normal to 
impaired glucose tolerance and then to diabetes. Preliminary analyses suggest that insulin resistance is a 
primary abnormality predisposing Pima Indians to develop impaired glucose tolerance, and that the 
development of diabetes occurs with subsequent pancreatic failure. 
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The Pima Indians of Arizona have the highest reported
prevalence and incidence of non-insulin-dependent
diabetes mellitus (NIDDM) of any population in
the world. A cross-sectional and longitudinal study
was begun in 1982 to determine the metabolic
characteristic(s) that is (are) predictive of the
development of NIDDM and to document the sequence
of metabolic events that occur with the transition from
normal to impaired glucose tolerance and then to
diabetes. Preliminary analyses suggest that insulin
resistance is a primary abnormality predisposing Pima
Indians to develop impaired glucose tolerance, and that
the development of diabetes occurs with subsequent
pancreatic failure. Diabetes Care 14 (Suppl. 3):685-90,
1991
T
he Pima Indians are a relatively genetically ho-
mogenous population who have lived in the same
hot, arid environment in Arizona for nearly 2000
years (1). They were traditionally an agricultural
society, making use of the Gila River and an extensive
system of irrigation canals to supply enough water to
grow sufficient produce to survive in this hostile envi-
ronment. In the latter part of the last century, and in the
early part of this century, the Gila River began to dry
up as a result of increased water use by upstream settlers
and ultimately with the damming of the river. The Pima
Indians were catapulted from a self-sufficient agrarian
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society to a "westernized" society that depended on
purchased (or government-issued) foods for their sur-
vival. With the abrupt radical change in life-style has
come obesity (2), and with the obesity has come the
highest reported prevalence and incidence of non-in-
sulin-dependent diabetes mellitus (NIDDM) of any pop-
ulation in the world (3).
Since the mid-1960s the residents of the Gila River
Indian Community have willingly participated in a lon-
gitudinal study of the development of NIDDM. Every 2
yr, members of the community >5 yr of age are ex-
amined in the clinic of the National Institute of Diabetes
and Digestive and Kidney Diseases. Many important ob-
servations regarding risk factors for the development of
NIDDM in the population have been identified in this
collaborative epidemiological effort. Some of the risk
factors identified among nondiabetic subjects have in-
cluded age, glucose intolerance, body mass index, and
parental diabetes (2).
Approximately 6 yr ago an in-depth longitudinal study
of a subset of the Pima population was begun with the
purposes of 7) defining the metabolic characteristic(s)
that is (are) predictive of the development of NIDDM
and 2) documenting the sequence of metabolic events
that occurs with the transition from normal to impaired
glucose tolerance and then to NIDDM. We report herein
preliminary analyses of the data collected in the cross-
sectional and early longitudinal phases of this study.
CROSS-SECTIONAL STUDIES
People with fasting glycemia >13.8 mM and NIDDM
are most often characterized by obesity, relatively low
plasma insulin concentrations, insulin resistance, and
increased rates of hepatic glucose production. In our
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initial cross-sectional studies, we determined the rela-
tionship between these metabolic abnormalities and
fasting glycemia among nondiabetic subjects and un-
treated diabetic patients.
The hyperinsulinemic-euglycemic clamp technique
was used to estimate insulin action in vivo at both phys-
iological (~600 pM) and maximally stimulating insulin
concentrations (-12,000 pM; Figs. 1 and 2). At both
insulin levels, people with NIDDM were uniformly in-
sulin resistant, i.e., they had very low rates of insulin-
mediated glucose disposal (4). However, there was no
significant correlation between fasting glycemia and in-
sulin action at either insulin level. Conversely, among
the nondiabetic subjects, there was a wide range of in-
sulin action, and the degree of insulin resistance was
proportional to the level of glycemia at both low and
maximally stimulating insulin concentrations.
Two important tentative conclusions can be drawn
from these data. First, although insulin resistance is uni-
formly present among those with NIDDM, it appears
that people with fasting glycemia of —16.6 mM are no
more resistant than those diabetic subjects with fasting
glycemia of —8.3 mM. Therefore, an additional meta-
bolic abnormality must occur to result in changes in
fasting glycemia in this range. Second, because insulin
action was significantly negatively correlated with gly-
cemia among nondiabetic subjects, insulin resistance
could be the mechanism of their impaired glucose tol-
erance in this group.
Studies of the insulin levels in these same subjects are
consistent with these measurements of insulin action.
Among diabetic subjects, there was a significant nega-
tive correlation between glycemia and fasting plasma
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FIG. 1. Relationship between insulin-mediated glucose
disposal rate and fasting plasma glucose concentration.
Glucose disposal rate was measured during a hyperinsu-
linemic (mean ± SE plasma insulin concentration 810 ±
30 pM) euglycemic (mean plasma glucose concentration
5.6 ± 0.02 mM) clamp. • , Diabetic subjects (r = 0.05, NS);
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FIG. 2. Relationship between insulin-mediated glucose
disposal rate and fasting plasma glucose concentration.
Glucose disposal rate was measured during a hyper-
insulinemic (mean ± SE plasma insulin concentration
10,428 ± 354 pM) euglycemic (mean plasma glucose con-
centration 5.6 ± 0.02 mM) clamp. • , Diabetic subjects
(r = 0.02, NS); O, nondiabetic subjects (r = -0.60, P <
0.01).
observed between the insulin response to an oral glu-
cose load or to a mixed meal (4). Among nondiabetic
subjects, those with the worst glucose tolerance had the
highest insulin levels; the insulin levels were as ex-
pected for their level of glycemia, with the use of sub-
jects with normal glucose tolerance as a reference (5).
These data further supported the hypothesis that insulin
resistance was a major cause of impaired glucose tol-
erance among nondiabetic subjects, but among diabetic
subjects impaired insulin secretion (and/or increased in-
sulin clearance) also occurred to contribute to the
pathogenesis of increasing glycemia.
In addition, among diabetic subjects, a strong corre-
lation was observed between fasting glycemia and the
rate of hepatic glucose production, as estimated with
tracer methodology and tritiated glucose (4; Fig. 4).
There was no correlation between glycemia and hepatic
glucose production rate among nondiabetic subjects (4).
Among diabetic subjects, there were also significant lin-
ear correlations between fasting glycemia, free fatty acid
levels, and rates of hepatic glucose production (4). Free
fatty acids may contribute to the stimulation of increased
hepatic glucose production by two mechanisms (6-8).
First, free fatty acid oxidation can provide the energy
needed for increased gluconeogenesis. Second, an in-
creased influx of free fatty acids into a limb results in an
increased efflux of lactate, presumably by the inhibition
of pyruvate dehydrogenase (9). The increased lactate
efflux from the limb to the liver can then provide a ready
supply of three-carbon substrates for gluconeogenesis.
These cross-sectional data suggest the following hy-
pothesis of the pathogenesis of NIDDM among Pima
Indians. Among nondiabetic subjects, impaired glucose
tolerance is a result of insulin resistance. The pancreas
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FIG. 3. Relationship between fasting plasma insulin and
glucose concentrations. • , Diabetic subjects (r = 0.69,
P < 0.01); o, nondiabetic subjects (r = 0.24, NS).
responds appropriately with increased insulin secretion,
resulting in the commonly observed hyperinsulinemia
among these subjects. More severe hyperglycemia re-
sults from the additional metabolic defect of failing pan-
creatic function and declining plasma insulin levels. By
indirect and possibly through direct effects, declining
plasma insulin levels result in increased hepatic glucose
production in subjects with preexisting insulin resis-
tance.
Inherent in these hypotheses is a primary role for in-
sulin resistance in the pathogenesis of NIDDM in this
population. Because NIDDM has significant and major
genetic determinants (10), the hypotheses would be
strengthened by evidence of genetic determinants of in-
sulin resistance, particularly among nondiabetic sub-
jects, i.e., before NIDDM develops. With this in mind,
we have analyzed the determinants of insulin resistance
among Pima Indians.
Obesity is commonly believed to be a major deter-
minant of insulin resistance in humans. Therefore, the
relationship between degree of obesity, as estimated by
densitometry, and insulin action in vivo was determined
in a large number of nondiabetic Pima Indians at both
physiological and maximally stimulating insulin con-
centrations (11-13; Figs. 5 and 6).
At physiological insulin concentrations, degree of
obesity was nonlinearly correlated with insulin action
(Fig. 5). However, above a body fat of 30% there was
no significant correlation between these two parame-
ters. Also, at any given degree of obesity there was
considerable variance in insulin action, suggesting the
importance of determinants of insulin action not related
to degree of obesity. At maximally stimulating insulin
concentrations, insulin action and degree of obesity
were linearly but more weakly correlated, i.e., obesity
accounted for even less of the variance in insulin action.
Thus, although there is evidence that the obese are more
insulin resistant, the impact of obesity on insulin action
is probably less than previously thought.
Multivariate analyses showed that, at physiological
insulin concentrations, obesity accounted for —36% of
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FIG. 4. Relationship between endogenous (hepatic) glu-
cose production rate and fasting plasma glucose concen-
tration. Endogenous glucose production rate was mea-
sured with [3-3H]glucose as tracer in the morning after an
overnight fast. • , Diabetic subjects (r = 0.90, P < 0.001);














FIG. 5. Relationship between insulin-mediated glucose
disposal rate and percentage body fat. Glucose disposal
rate was measured during a hyperinsulinemic (mean ± SE
plasma insulin concentration 756 ± 18 pM) euglycemic
(mean plasma glucose concentration 5.2 ± 0 mM) clamp.
Percentage body fat was estimated by densitometry (n =
213, r = -0 .61 , P < 0.0001). EMBS, estimated metabolic
body size.
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FIG. 6. Relationship between maximal insulin-mediated
glucose disposal rate and percentage body fat. Glucose
disposal rate was measured during a hyperinsulinemic
(mean ± SE plasma insulin 11,886 ± 210 pM) euglycemic
(mean ± SE plasma glucose concentration 5.2 ± 0.06 mM)
clamp. Percentage body fat was determined by densitom-
etry (n = 213, r = -0.30, P < 0.0001). EMBS, estimated
metabolic body size.
stimulating insulin concentrations accounted for only
— 15% of the variance in insulin action (13). In addition,
age and sex differences did not account for much of the
variance in insulin action not accounted for by obesity
(13). The differential impact of obesity on insulin action
at physiological versus maximally stimulating insulin
concentrations is not fully explained. However, as we
have previously suggested, it may relate to the reduced
skeletal muscle capillary density that occurs with obesity
(14).
What emerged from these analyses, however, was
that insulin action, independent of the effect of obesity,
age, and sex, aggregates in families (13; Fig. 7). This
familial aggregation was consistent with either signifi-
cant genetic factors and/or family-based environmental
factors being significant determinants of insulin action
in vivo among Pima Indians. Because the subjects were
studied after living on our metabolic ward for ~1 wk,
and because they were adults who frequently did not
share the same home environment, the data are most
consistent with a hypothetical role for genetic factors in
determining insulin action in this population.
To summarize the cross-sectional results, it appeared
that, among nondiabetic subjects, insulin resistance is a
major determinant of impaired glucose tolerance and
that the insulin resistance is probably a result of both
genetic and so-called "environmental factors" such as
degree of obesity. More severe hyperglycemia results
from the pancreatic failure superimposed on insulin re-
sistance.
LONGITUDINAL STUDIES
These hypotheses of the pathogenesis of NIDDM among
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FIG. 7. Maximal insulin-stimulated glucose disposal rate
(MaxM) adjusted for age, sex, and percentage body fat is
shown for each subject (*). Subjects are grouped by family
(bars) and families are ranked by family mean adjusted
MaxM ( - ) . Family effect on MaxM was significantly in-
dependent of percentage body fat, age, and sex (P <
0.0001). EMBS, estimated metabolic body size.
may not accurately reflect the longitudinal sequence of
events. Only prospective longitudinal studies have the
potential to unequivocally determine the pathogenetic
mechanisms of the development of NIDDM. Our lon-
gitudinal studies are still ongoing but some preliminary
observations can be reported.
The cross-sectional data suggested that impaired glu-
cose tolerance was largely a result of insulin resistance
rather than being a result of any deficit in insulin secre-
p IO.OOOI p«O.OOO3
6.0r
Normal Impaired Normal Impaired
FIG. 8. Longitudinal changes in subjects with normal glu-
cose tolerance in whom glucose tolerance became im-
paired over 21.5 mo of follow-up (range 10-45 mo).
Individual values and means (bars) are shown for insulin
area during an oral glucose tolerance test (OGTT) and
glucose uptake during hyperinsulinemia (—780 pM) and
euglycemia (—5.5 mM).
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FIG. 9. Insulin and glucose areas derived from oral glu-
cose tolerance tests (OGTTs) on 278 Pima Indians. Shown
are means (with 95% confidence limits) for each of 4
study groups: subjects with normal glucose tolerance
(n = 151), subjects with impaired glucose tolerance (IGT;
n = 90), subjects with fasting plasma (FG) glucose val-
ues <6.6 mM (n = 11), and subjects with FG levels >6.6
mM (n = 26). Regression lines are shown for nondiabetic
and diabetic subjects. Arrow, mean value for subjects be-
fore and after development of IGT (n = 24).
tion. We have reported longitudinal observations on 24
Pima Indians who initially had normal glucose tolerance
but developed impaired glucose tolerance and with an
increase in the 2-h postglucose load glucose level of
>1.6 mM (5). The longitudinal data in these subjects
closely parallel the cross-sectional data.
The development of impaired glucose tolerance in the
24 subjects was associated with increasing body weight,
worsening insulin resistance, and increasing insulin lev-
els (5; Fig. 8). Of particular importance was the obser-
vation that the insulin responses to oral glucose did not
become relatively deficient but increased as predicted
by the relationship between insulin and glucose levels
among subjects with normal glucose tolerance (Fig. 9).
Thus, in Pima Indians, impaired glucose tolerance ap-
pears to be a result only of insulin resistance. Pancreatic
function in these subjects is "normal," as defined by
subjects with normal glucose tolerance. However, we
do not have a long enough follow-up of these 24 sub-
jects to know what happens to their insulin action and
insulin secretion if and when their glucose tolerance
deteriorates further.
Some of these subjects, who made the transition from
normal to impaired glucose tolerance did develop
NIDDM during follow-up. In addition, some people
who had impaired glucose tolerance at entry into the
study have developed NIDDM during follow-up. As re-
ported previously, among 145 nondiabetic subjects
studied and followed for an average of 1.8 yr, 18 people
developed NIDDM (15). At entry into the study, these
subjects were more hyperinsulinemic and insulin resist-
ant than the nondiabetic subjects who did not develop
NIDDM. This was the first suggestion, although still pre-
liminary, that insulin resistance is a predictor of the de-
velopment of NIDDM among nondiabetic Pima Indians.
Whether these data will hold up with a longer duration
of follow-up remains to be seen. Nonetheless, our pre-
liminary longitudinal data appear to corroborate tenta-
tive conclusions drawn on the basis of the cross-sec-
tional analyses.
Insulin resistance appears to be a primary abnormality
that predisposes Pima Indians to develop NIDDM at an
increased rate. Insulin resistance leads to an impaired
glucose tolerance and this is followed by pancreatic fail-
ure that is then associated with marked fasting hyper-
glycemia. Whether the pancreatic failure is a conse-
quence of insulin resistance (i.e., p-cell exhaustion or
glucotoxicity) or a result of other predetermined genetic
factors is uncertain. A more thorough understanding of
all of these events will be forthcoming when sufficient
numbers of people have been observed to proceed
through the proposed sequence of metabolic events in
the transition from normal glucose tolerance to NIDDM.
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